BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12414446)

  • 1. Alterations in mitochondrial function in a mouse model of hypertrophic cardiomyopathy.
    Lucas DT; Aryal P; Szweda LI; Koch WJ; Leinwand LA
    Am J Physiol Heart Circ Physiol; 2003 Feb; 284(2):H575-83. PubMed ID: 12414446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy.
    Vakrou S; Liu Y; Zhu L; Greenland GV; Simsek B; Hebl VB; Guan Y; Woldemichael K; Talbot CC; Aon MA; Fukunaga R; Abraham MR
    Sci Rep; 2021 Jun; 11(1):13163. PubMed ID: 34162896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy.
    Nagueh SF; Chen S; Patel R; Tsybouleva N; Lutucuta S; Kopelen HA; Zoghbi WA; Quiñones MA; Roberts R; Marian AJ
    J Mol Cell Cardiol; 2004 May; 36(5):663-73. PubMed ID: 15135661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy.
    Tardiff JC; Hewett TE; Palmer BM; Olsson C; Factor SM; Moore RL; Robbins J; Leinwand LA
    J Clin Invest; 1999 Aug; 104(4):469-81. PubMed ID: 10449439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males.
    Luckey SW; Mansoori J; Fair K; Antos CL; Olson EN; Leinwand LA
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H838-45. PubMed ID: 17012357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased left ventricular ejection fraction in transgenic mice expressing mutant cardiac troponin T-Q(92), responsible for human hypertrophic cardiomyopathy.
    Lim DS; Oberst L; McCluggage M; Youker K; Lacy J; DeMayo F; Entman ML; Roberts R; Michael LH; Marian AJ
    J Mol Cell Cardiol; 2000 Mar; 32(3):365-74. PubMed ID: 10731436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular genetic basis for hypertrophic cardiomyopathy.
    Marian AJ; Roberts R
    J Mol Cell Cardiol; 2001 Apr; 33(4):655-70. PubMed ID: 11273720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial hypertrophic cardiomyopathy: a paradigm of the cardiac hypertrophic response to injury.
    Marian AJ; Roberts R
    Ann Med; 1998 Aug; 30 Suppl 1():24-32. PubMed ID: 9800880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
    Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy.
    Vikstrom KL; Factor SM; Leinwand LA
    Mol Med; 1996 Sep; 2(5):556-67. PubMed ID: 8898372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A transgenic rabbit model for human hypertrophic cardiomyopathy.
    Marian AJ; Wu Y; Lim DS; McCluggage M; Youker K; Yu QT; Brugada R; DeMayo F; Quinones M; Roberts R
    J Clin Invest; 1999 Dec; 104(12):1683-92. PubMed ID: 10606622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic Cardiomyopathy.
    Coppini R; Mazzoni L; Ferrantini C; Gentile F; Pioner JM; Laurino A; Santini L; Bargelli V; Rotellini M; Bartolucci G; Crocini C; Sacconi L; Tesi C; Belardinelli L; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Poggesi C
    Circ Heart Fail; 2017 Mar; 10(3):. PubMed ID: 28255011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy.
    Tsybouleva N; Zhang L; Chen S; Patel R; Lutucuta S; Nemoto S; DeFreitas G; Entman M; Carabello BA; Roberts R; Marian AJ
    Circulation; 2004 Mar; 109(10):1284-91. PubMed ID: 14993121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible triggers for hypertrophic cardiomyopathy are established in the early postnatal period.
    Cannon L; Yu ZY; Marciniec T; Waardenberg AJ; Iismaa SE; Nikolova-Krstevski V; Neist E; Ohanian M; Qiu MR; Rainer S; Harvey RP; Feneley MP; Graham RM; Fatkin D
    J Am Coll Cardiol; 2015 Feb; 65(6):560-9. PubMed ID: 25677315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy.
    Tardiff JC; Factor SM; Tompkins BD; Hewett TE; Palmer BM; Moore RL; Schwartz S; Robbins J; Leinwand LA
    J Clin Invest; 1998 Jun; 101(12):2800-11. PubMed ID: 9637714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing a new human hypertrophic cardiomyopathy-specific model using human embryonic stem cells.
    Cai H; Li B; Bai A; Huang J; Zhan Y; Sun N; Liang Q; Xu C
    Exp Cell Res; 2020 Feb; 387(1):111736. PubMed ID: 31759053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.
    Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL
    Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burst-Like Transcription of Mutant and Wildtype
    Montag J; Kowalski K; Makul M; Ernstberger P; Radocaj A; Beck J; Becker E; Tripathi S; Keyser B; Mühlfeld C; Wissel K; Pich A; van der Velden J; Dos Remedios CG; Perrot A; Francino A; Navarro-López F; Brenner B; Kraft T
    Front Physiol; 2018; 9():359. PubMed ID: 29686627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy.
    Konhilas JP; Watson PA; Maass A; Boucek DM; Horn T; Stauffer BL; Luckey SW; Rosenberg P; Leinwand LA
    Circ Res; 2006 Mar; 98(4):540-8. PubMed ID: 16439687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of MEKK1 in hypertrophic cardiomyopathy.
    Konhilas JP; Boucek DM; Horn TR; Johnson GL; Leinwand LA
    Int Heart J; 2010 Jul; 51(4):277-84. PubMed ID: 20716846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.